Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Autologous adipose-derived regenerative cell (ADRC) therapy is a medical procedure designed to address partial thickness rotator cuff tears by utilizing the patient's own adipose (fat) tissue. This innovative approach aims to promote healing of the tendons surrounding the shoulder joint, which are critical for shoulder function. Traditional conservative treatments, such as physical therapy or steroid injections, may alleviate symptoms but do not effectively restore the integrity of a torn rotator cuff. Surgical interventions can be successful; however, they carry a significant risk of re-rupture. One contributing factor to the rotator cuff's poor healing response is the inadequate supply of stem cells at the tendon-bone interface, which are essential for the development of connective tissue, lymphatic tissue, and blood vessels. The ADRC therapy procedure involves several key steps: first, the harvesting of adipose tissue, typically performed through liposuction under local anesthesia from areas such as the trunk or thigh. Following harvesting, the adipose tissue is cleaned, filtered, and processed to isolate the regenerative cells. This processing includes incubation with an enzymatic reagent to facilitate cell isolation and dissociation, followed by multiple steps of filtration, washing, and centrifugation. Once prepared, the autologous stem cell product is injected into the supraspinatus tendon and its surrounding area, guided by ultrasound to ensure precision. The injection site is then dressed to promote healing. Although the procedure is still under investigation in clinical trials, preliminary results indicate promising outcomes in repairing partially torn rotator cuffs, with a low incidence of side effects and re-tears.
© Copyright 2026 Coding Ahead. All rights reserved.
The autologous adipose-derived regenerative cell (ADRC) therapy is indicated for the treatment of partial thickness rotator cuff tears. This procedure is particularly relevant for patients who have not achieved satisfactory results from conservative treatments such as physical therapy or steroid injections, which primarily address symptoms rather than the underlying structural damage. Additionally, it may be considered for individuals who are at risk of re-rupture following surgical interventions, given the rotator cuff's known poor healing response.
The procedure for autologous adipose-derived regenerative cell (ADRC) therapy involves several critical steps to ensure the effective treatment of partial thickness rotator cuff tears.
Post-procedure care for patients undergoing autologous adipose-derived regenerative cell (ADRC) therapy typically includes monitoring the injection site for any signs of complications, such as infection or excessive swelling. Patients may be advised to limit shoulder movement for a specified period to allow for optimal healing. Follow-up appointments are essential to assess the effectiveness of the treatment and to monitor recovery progress. While the procedure shows promise, ongoing clinical trials will continue to evaluate its long-term efficacy and safety.
| Short Descr | ADRC THER PRTL RC TEAR NJX | Medium Descr | ADRC THER PRTL THICKNESS RC TEAR NJX TENDON UNI | Long Descr | Autologous adipose-derived regenerative cell (ADRC) therapy for partial thickness rotator cuff tear; injection into supraspinatus tendon including ultrasound guidance, unilateral | Status Code | Carriers Price the Code | Global Days | YYY - Carrier Determines Whether Global Concept Applies | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 1 - 150% payment adjustment for bilateral procedures applies. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Multiple Reduction Applies | ASC Payment Indicator | Non office-based surgical procedure added in CY 2008 or later; payment based on OPPS relative payment weight. | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2023-01-01 | Added | First appearance in codebook. |
| 2022-07-01 | Added | Code added. |
Get instant expert-level medical coding assistance.